• Cabozantinib in RCC: Workflow & Adaptation

  2026-09-11

  Use Cabozantinib (XL184) to connect receptor tyrosine kinase inhibition with angiogenesis, phosphoproteomic remodeling, and motility phenotypes. This workflow pairs acute and chronic exposure in renal cell carcinoma models, helping researchers distinguish direct drug effects from adaptation.

• GSH and GSSG Assay Kit in Hypoxia Biology

  2026-09-11

  The GSH and GSSG Assay Kit provides a practical route to reduced glutathione detection and oxidized glutathione measurement in hypoxic tumor models. This guide translates tumor immunometabolism into sampling, normalization, and interpretation decisions for more rigorous redox state analysis.

• T0070907: A Practical PPARγ Antagonist Guide

  2026-09-10

  T0070907 is a nanomolar PPARγ antagonist for separating receptor-dependent transcription from downstream effects in adipogenesis, inflammatory foam-cell, and cancer-cell assays. This workflow-focused guide covers formulation, assay design, RXRα/PPARγ pathway testing, cell-cycle analysis, and troubleshooting.

• GRE Inhibits Melanogenesis Through CREB/MITF

  2026-09-10

  The reference study evaluates a combined glabridin, resveratrol, and ellagic acid formulation, identifying GRE as the strongest tested composition for suppressing melanin production, oxidative stress, and nitric oxide release in cell-based assays. Its value lies in connecting phenotypic endpoints with CREB/MITF pathway regulation, while also clarifying the experimental controls needed for pigmentation and inflammation studies.

• Ibuprofen as an Emerging Contaminant: Review Insights

  2026-09-09

  Jan-Roblero and Cruz-Maya’s review reframes ibuprofen as an environmental contaminant shaped by high consumption, incomplete removal, persistence, and biological effects in aquatic and soil systems. Its main practical contribution is to connect contaminant toxicology with bacterial biodegradation as a possible, but still developing, remediation strategy.

• Chlorambucil: Beyond the Viability Readout

  2026-09-09

  Chlorambucil is a nitrogen mustard alkylating agent whose DNA damage can produce growth arrest or cell death. This guide applies a time-resolved assay framework to distinguish those outcomes and improve interpretation of cancer-response experiments.

• Protoporphyrin IX for Ferroptosis Assays

  2026-09-08

  Protoporphyrin IX is a photodynamic compound that can support controlled studies of heme formation, light-triggered cell injury, and iron-handling biology. This guide separates established product chemistry from exploratory hepatocellular carcinoma ferroptosis applications and provides practical workflows, controls, and troubleshooting strategies.

• METTL16–SENP3–LTF Axis in HCC Ferroptosis

  2026-09-07

  Wang et al. identify a METTL16–SENP3–LTF signaling axis that limits ferroptosis by controlling iron availability in hepatocellular carcinoma. Their integrated cellular, organoid, animal, and clinical analyses connect m6A-dependent RNA regulation with LTF stabilization and provide a framework for testing ferroptosis-sensitizing strategies.

• L-Ornithine for Reliable Cell Assays

  2026-09-07

  This scenario-based guide shows how L-Ornithine, SKU B8919, can support controlled urea-cycle, liver–brain, viability, proliferation, and cytotoxicity experiments. It covers solvent compatibility, stock preparation, mechanistic controls, data interpretation, and evidence-based reagent selection.

• BRD4770: G9a Inhibition in Cancer Research

  2026-09-05

  BRD4770 is a research-grade G9a histone methyltransferase inhibitor for connecting H3K9 methylation changes with senescence, cell death, and proliferation phenotypes. This workflow-focused guide shows how to use it in PANC-1 assays, manage its unusual solubility profile, and interpret findings alongside BRD4–RAC1 pathway research.

• ECL Western Blotting Substrate: Protocol Guide

  2026-09-04

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for sensitive, nonradioactive protein detection on immunoblots. It is intended for HRP-linked Western blot assays using X-ray film or CCD imaging, not fluorescent or radioisotopic workflows; store the product at +4°C and use prepared solution promptly.

• Bedaquiline Beyond TB: A Translational Energy Strategy

  2026-09-04

  Bedaquiline offers a powerful framework for studying energy metabolism across pathogen and tumor models. This thought-leadership analysis connects its direct inhibition of Mycobacterium tuberculosis F1FO-ATP synthase with host-directed tuberculosis strategies and emerging cancer stem cell research, while defining practical boundaries for translational interpretation.

• PF-562271 HCl: FAK/Pyk2 Assay Workflows

  2026-09-04

  PF-562271 HCl enables time-resolved FAK/Pyk2 pathway studies that connect adhesion, migration, and tumor-cell behavior with circulating cancer-associated macrophage-like cells. This workflow-focused guide covers dose design, CAML-oriented phenotyping, reversible inhibition, and troubleshooting for reproducible cancer research.

• Puromycin dihydrochloride: Reliable Cell Assays

  2026-09-03

  A scenario-based guide to using Puromycin dihydrochloride for cell-line selection, translation studies, and interpretation of viability data. It explains how SKU B7587 supports practical, reproducible workflows through defined concentration ranges, solubility, and storage guidance.

• MCL-1 Dependence in Breast Cancer: Canonical Apoptosis

  2026-09-02

  This 2021 Cell Death & Differentiation study shows that established breast tumors depend on MCL-1 primarily because of its canonical anti-apoptotic function, rather than an independent non-apoptotic activity. Genetic deletion and pharmacological inhibition both required BAX/BAK to produce tumor control, supporting apoptosis-focused strategies for studying MCL-1 dependence.

7994 records 1/533 page Next 12345 下5页 Last page